BBLG

NASDAQ 已收盘

Bone Biologics

0.27 USD
▼-0.01-2.40%
盘后 0.28 +3.72%
2026-11-20
市值
$909.96K
市盈率
—
EPS
-1.24
股息率
—
52 周区间
0.26 – 2.39
成交量
36.49K
Beta
0.90
目标价
—
52W 低 0.2652W 高 2.39
价格走势

公司简介

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration. The company also develops NB1, a NELL-1/DBM fusion device for use in lumbar spinal fusion, as well as spine implants, non-union trauma cases, and osteoporosis applications. It serves spine surgeons and patients with a skeletal bone defect or b...